NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

eVusheld Assessment reaL wORld Effectiveness in the VA Health System
eVusheld Assessment reaL wORld Effectiveness in the VA Health System

NCT05663957

CompletedN/A

Sponsor: AstraZeneca

Conditions: SARS-CoV-2, COVID-19

Interventions: Evusheld

Countries: United States

An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-embedded retrospective cohort study to assess the real-world effectiveness of EVUSHELD against SARS-CoV-2 infection, COVID-19-related hospitalization, and other COVID-19 related outcomes in the total EUA-eligible patient population in the Department of Veterans Affairs (VA) Health System.

Eligibility overview

Sex: ALL

Age: 12 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Receipt of EVUSHELD under the FDA EUA for EVUSHELD
2. Eligibility to access EVUSHELD use under the EUA.

Exclusion Criteria:

* None
Locations (1)
  • Salt Lake City, Utah, United States